Cencora Inc (BSP:C1CO34)
R$ 717.12 0 (0%) Market Cap: 277.21 Bil Enterprise Value: 285.61 Bil PE Ratio: 33.25 PB Ratio: 75.37 GF Score: 85/100

Amerisourcebergen Corp at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 02:15PM GMT
Release Date Price: R$388.2 (-3.62%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. Start with our next session here with AmerisourceBergen. I'm Steven Valiquette, the healthcare services analyst here at Barclays. With us from the company, we have Steve Collis, the CEO; and also Jim Cleary, the CFO, up here on stage with me. And then Bennett Murphy is in the audience from Investor Relations as well. This will be a fireside chat. So I think with that, I guess we'll just dive right in.

Steven H. Collis
AmerisourceBergen Corporation - Chairman, President & CEO

Okay. Good.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay. Great. So maybe first topic here, obviously, for ABC, a hallmark of the company has been specialty drug distribution. It's been a great source of stronger-than-average profit growth for the company for a long time now and depending that could be accelerated further here over the next couple of years, potentially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot